No correlation between NF1 mutation position and risk of optic pathway glioma in 77 unrelated NF1 patients.

PubWeight™: 0.86‹?›

🔗 View Article (PMID 26969325)

Published in Hum Genet on March 11, 2016

Authors

Sonja Hutter1, Rosario M Piro2,3,4,5, Sebastian M Waszak6, Hildegard Kehrer-Sawatzki7, Reinhard E Friedrich8, Alvaro Lassaletta9, Olaf Witt3,10,11,12, Jan O Korbel6, Peter Lichter2,3, Martin U Schuhmann13,14,15, Stefan M Pfister1,3,11,12, Uri Tabori9, Victor F Mautner16, David T W Jones17,18

Author Affiliations

1: Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.
2: Division of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
3: German Cancer Consortium (DKTK) Core Center Heidelberg, Heidelberg, Germany.
4: Institute of Computer Science, Freie Universität Berlin, Berlin, Germany.
5: Institute of Medical Genetics and Human Genetics, Charité University Hospital, Berlin, Germany.
6: European Molecular Biology Laboratory (EMBL), Genome Biology Research Unit, Heidelberg, Germany.
7: Institute of Human Genetics, University of Ulm, Ulm, Germany.
8: Department of Oral and Cranio-Maxillofacial Surgery, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
9: Division of Hematology/Oncology, Department of Pediatrics, Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.
10: Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
11: Department of Pediatric Oncology, Hematology and Immunology, Heidelberg University Hospital, Heidelberg, Germany.
12: National Center for Tumor Diseases (NCT), Heidelberg, Germany.
13: Department of Neurosurgery, University Hospital Tübingen, Tübingen, Germany.
14: Centre for Neurofibromatosis, Centre for Rare Diseases Tübingen, Tübingen, Germany.
15: German Cancer Consortium (DKTK) Partner Site Tübingen, Tübingen, Germany.
16: Department of Neurology, University Hospital Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany. v.mautner@uke.de.
17: Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. davidjones@cantab.net.
18: German Cancer Consortium (DKTK) Core Center Heidelberg, Heidelberg, Germany. davidjones@cantab.net.

Articles cited by this

VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res (2012) 15.90

Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference. Arch Neurol (1988) 8.61

Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects. Hum Mutat (2000) 3.87

Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations. Ann Neurol (2007) 2.75

Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study. J Pediatr (1994) 2.63

Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF1 Optic Pathway Glioma Task Force. Ann Neurol (1997) 2.28

An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in exon 17 of the NF1 gene (c.2970-2972 delAAT): evidence of a clinically significant NF1 genotype-phenotype correlation. Am J Hum Genet (2006) 2.23

NF1 microdeletions in neurofibromatosis type 1: from genotype to phenotype. Hum Mutat (2010) 1.47

Unified representation of genetic variants. Bioinformatics (2015) 1.24

Clinical characterisation of 29 neurofibromatosis type-1 patients with molecularly ascertained 1.4 Mb type-1 NF1 deletions. J Med Genet (2010) 1.23

A molecular analysis of individuals with neurofibromatosis type 1 (NF1) and optic pathway gliomas (OPGs), and an assessment of genotype-phenotype correlations. J Med Genet (2011) 1.19

Neurofibromatosis type 1 molecular diagnosis: what can NGS do for you when you have a large gene with loss of function mutations? Eur J Hum Genet (2014) 1.00

Clustering of mutations in the 5' tertile of the NF1 gene in Slovakia patients with optic pathway glioma. Neoplasma (2013) 0.96

Whole exome sequencing reveals that the majority of schwannomatosis cases remain unexplained after excluding SMARCB1 and LZTR1 germline variants. Acta Neuropathol (2014) 0.75